Is Integra LifeSciences Stock a Good Investment?
Integra LifeSciences Investment Advice | IART |
- Examine Integra LifeSciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Integra LifeSciences' leadership team and their track record. Good management can help Integra LifeSciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Integra LifeSciences' business and its evolving consumer preferences.
- Compare Integra LifeSciences' performance and market position to its competitors. Analyze how Integra LifeSciences is positioned in terms of product offerings, innovation, and market share.
- Check if Integra LifeSciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Integra LifeSciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Integra LifeSciences Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Integra LifeSciences Holdings is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Integra LifeSciences Stock
Researching Integra LifeSciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Integra LifeSciences has Price/Earnings To Growth (PEG) ratio of 1.11. The entity recorded a loss per share of 0.09. The firm had not issued any dividends in recent years. Integra LifeSciences had 2:1 split on the 4th of January 2017.
To determine if Integra LifeSciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Integra LifeSciences' research are outlined below:
| Integra LifeSciences generated a negative expected return over the last 90 days | |
| Integra LifeSciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 1.61 B. Net Loss for the year was (6.94 M) with profit before overhead, payroll, taxes, and interest of 959.12 M. | |
| Over 92.0% of the company shares are owned by institutional investors |
Integra LifeSciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Integra LifeSciences Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Integra LifeSciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Integra LifeSciences' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.7 B.Basic technical analysis of Integra Stock
As of the 28th of March, Integra LifeSciences retains the Risk Adjusted Performance of 0.0042, standard deviation of 3.1, and Market Risk Adjusted Performance of (0.01). Integra LifeSciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Integra LifeSciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Integra LifeSciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Integra LifeSciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Integra LifeSciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Integra LifeSciences' Outstanding Corporate Bonds
Integra LifeSciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Integra LifeSciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Integra bonds can be classified according to their maturity, which is the date when Integra LifeSciences Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US457985AM13 Corp BondUS457985AM13 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Integra LifeSciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Integra LifeSciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0042 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 2.25 | |||
| Coefficient Of Variation | (28,013) | |||
| Standard Deviation | 3.1 | |||
| Variance | 9.63 | |||
| Information Ratio | 0.0105 | |||
| Jensen Alpha | 0.049 | |||
| Total Risk Alpha | 0.1735 | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 19.25 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 4.35 | |||
| Skewness | 0.7 | |||
| Kurtosis | 3.12 |
| Risk Adjusted Performance | 0.0042 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 2.25 | |||
| Coefficient Of Variation | (28,013) | |||
| Standard Deviation | 3.1 | |||
| Variance | 9.63 | |||
| Information Ratio | 0.0105 | |||
| Jensen Alpha | 0.049 | |||
| Total Risk Alpha | 0.1735 | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 19.25 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 4.35 | |||
| Skewness | 0.7 | |||
| Kurtosis | 3.12 |
Consider Integra LifeSciences' intraday indicators
Integra LifeSciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Integra LifeSciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Integra LifeSciences time-series forecasting models is one of many Integra LifeSciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Integra LifeSciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Integra Stock media impact
Far too much social signal, news, headlines, and media speculation about Integra LifeSciences that are available to investors today. That information is available publicly through Integra media outlets and privately through word of mouth or via Integra internal channels. However, regardless of the origin, that massive amount of Integra data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Integra LifeSciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Integra LifeSciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Integra LifeSciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Integra LifeSciences alpha.
Integra LifeSciences Corporate Executives
Elected by the shareholders, the Integra LifeSciences' board of directors comprises two types of representatives: Integra LifeSciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Integra. The board's role is to monitor Integra LifeSciences' management team and ensure that shareholders' interests are well served. Integra LifeSciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Integra LifeSciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lea Knight | Executive CFO | Profile |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.